| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/18/2002 | CN1369501A Gene of 26S proteinase alpha subunit for regulating degradation of mouseearcress' abnormal protein |
| 09/18/2002 | CN1090973C TC-99m marked peptide for imaging |
| 09/17/2002 | USRE37850 Recombinant human endothelial cell growth factor |
| 09/17/2002 | US6453242 Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites |
| 09/17/2002 | US6452069 SF3 promoter and methods of use |
| 09/17/2002 | US6452066 GENOMIC DNA FRAGMENTS CONTAINING REGULATORY AND CODING SEQUENCES FOR THE β2-SUBUNIT OF THE NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR AND TRANSGENIC ANIMALS MADE USING THESE FRAGMENTS OR MUTATED FRAGMENTS |
| 09/17/2002 | US6452065 Transgenic mouse expressing non-native wild-type and familial Alzheimer's Disease mutant presenilin 1 protein on native presenilin 1 null background |
| 09/17/2002 | US6451997 Kits for detecting chromosomal rearrangements |
| 09/17/2002 | US6451995 Single chain FV polynucleotide or peptide constructs of anti-ganglioside GD2 antibodies, cells expressing same and related methods |
| 09/17/2002 | US6451993 Polynucleotides encoding human excitatory amino acid transporter 4 (EAAT4) |
| 09/17/2002 | US6451992 Antithrombin activity; veterinary vaccines |
| 09/17/2002 | US6451987 Ion exchange chromatography of proteins and peptides |
| 09/17/2002 | US6451986 Conjugating a protein with polyethylene glycol (peg), by deleting amino residue(s); for example, replacing protein arginine residues with lysine residues that provide a peg attachment site; bioactivity |
| 09/17/2002 | US6451981 Inhibitor of cellular adhesion, migration or infiltration into areas of tissue damage, injury, or transplant |
| 09/17/2002 | US6451979 Methods of treatment using NBS-1, antibodies and proteins thereto, and uses of the antibodies |
| 09/17/2002 | US6451978 Pure antithrombin-iii, the antithrombin isoforms at-iii alpha and at-iii beta, and/or histidine-rich glycoprotein by usng a cation exchange gel wherein the cation exchanger group is attached to the gel matrix by a linear polymer chain |
| 09/17/2002 | US6451976 Bi-or multifunctional molecules based on a dendroaspin scaffold |
| 09/17/2002 | US6451975 Mixing with acid to solubilize; precipitation; free of myofibrils and sarcomeres |
| 09/17/2002 | US6451974 Method of acylating peptides and novel acylating agents |
| 09/17/2002 | US6451971 Polypeptide cell adhesion inhibitors; antimetastasis and anticarcinogenic agents |
| 09/17/2002 | US6451970 Peptide derivatives |
| 09/17/2002 | US6451968 Hoogsteen type base pairing in triplex motif; diagnosis; heat resistance; detection of point mutations, restriction enzyme sites, and transcription inhibition |
| 09/17/2002 | US6451840 Regulation of T cell-mediated immunity by tryptophan |
| 09/17/2002 | US6451769 Compositions and methods for administering Borrelia DNA |
| 09/17/2002 | US6451765 Methods for treating breast cancer using Mammastatin |
| 09/17/2002 | US6451764 VEGF-related protein |
| 09/17/2002 | US6451763 Retinal pigmented epithelium derived neurotrophic factor and methods of use |
| 09/17/2002 | US6451760 Treatment of inflammation using a 2F1 polypeptide or an antibody thereto |
| 09/17/2002 | US6451759 Noncleavable Fas ligand |
| 09/17/2002 | US6451604 Polynucleotides; nucleotide sequence and complement; genetic engineering |
| 09/17/2002 | US6451597 Method for enhanced protein stabilization and for production of cell lines useful for production of such stabilized proteins |
| 09/17/2002 | US6451596 Helper adenovirus vectors |
| 09/17/2002 | US6451592 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 09/17/2002 | US6451578 Hepatitis, amino acid sequences and nucleic acids |
| 09/17/2002 | US6451573 Proteinase inhibitor, precursor thereof and genetic sequences encoding same |
| 09/17/2002 | US6451562 Polypeptides encoding myeloid progenitor inhibitory factor-1 (MPIF-1) polynucleotides |
| 09/17/2002 | US6451561 Growth hormone variants |
| 09/17/2002 | US6451560 Prokaryotic expression system characterized by alterations to the dlt operon whereby expression of genes encoded therein may be regulated to limit the availability of polypeptides encoded by said genes. |
| 09/17/2002 | US6451558 Genes in the control of hematopoiesis |
| 09/17/2002 | US6451557 Method for producing, in yeast, a hydroxylated triple helical protein, and yeast host cells useful in said method |
| 09/17/2002 | US6451556 EF-Tu |
| 09/17/2002 | US6451554 Purified nucleic acid sequence encoding a sodium channel protein wherein said nucleic acid sequence comprises the coding portion of the nucleic acid sequence and producing a mammalian sensory neuron sodium channel protein, wherein the |
| 09/17/2002 | US6451546 Plant glurs of the invention may function as signal transducers involved in the regulation of plant growth. the invention also relates to the identification of compounds that modulate the activity of the plant glur and herbicides |
| 09/17/2002 | US6451545 Monoclonal antibody specific to anti-human fibrin monomer, process for producing the same, hybridomas, and immunoassay method |
| 09/17/2002 | US6451543 Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides |
| 09/17/2002 | US6451541 Chaperones capable of binding to prion proteins and distinguishing the isoforms PrPc and PrPsc |
| 09/17/2002 | US6451534 Kvlqt1 and kcne1 which are genes associated with long qt syndrome. additional sequence data for the two genes are also disclosed. mutations in kvlqt1 which result in long qt syndrome. the intron/exon junction sequence data allow for the |
| 09/17/2002 | US6451528 Isolated nucleic acid encoding sperm-specific protein kinase a anchoring proteins from mammalian species, recombinant expression constructs encoding said mammalian sperm-specific protein kinase a anchoring proteins, cells transformed with |
| 09/17/2002 | US6451523 Variant form of the receptor for the obese gene product. the invention relates to methods of detecting this receptor variant in cells and tissues of obese individuals. |
| 09/17/2002 | US6451347 Complexing oxidized or deamidated human growth hormone with metal; precipitation, isolation |
| 09/17/2002 | US6451326 Cosmetic compositions |
| 09/17/2002 | US6451324 Ryegrass pollen allergen |
| 09/17/2002 | US6451323 Recombinant newcastle disease virus RNA expression systems and vaccines |
| 09/17/2002 | US6451322 Retrovirus like particles made non infectious by a plurality of mutations |
| 09/17/2002 | US6451320 Combined hepatitis and herpesvirus antigen compositions |
| 09/17/2002 | US6451318 Secreted proteins |
| 09/17/2002 | US6451317 Immunogenic conjugates comprising a Group B meningococcal porin and an H influenzae polysaccharide |
| 09/17/2002 | US6451315 Compounds and methods for the diagnosis and treatment of B. microti infection |
| 09/17/2002 | US6451314 MHC conjugates useful in ameliorating autoimmunity |
| 09/17/2002 | US6451313 Heterotetramer; expression vectors encoding heavy and light chains; viricides |
| 09/17/2002 | US6451311 An antibody which binds procalcitonin but not free calcitonin, free katacalcin and free n-procalcitonin; used as an in vitro or in vivo diagnostic agent |
| 09/17/2002 | US6451310 Preventing t cell activation of b cells by administering antibody cabable of binding protein recognized by monoclonal antibody 5c8 |
| 09/17/2002 | US6451308 Administering mutant polypeptide to treat rheumatoid arthritis and as immunomodulator |
| 09/17/2002 | US6451306 Specific protocol for use in grafting donor cells genetically modified to produce nerve growth factors into grafting sites within the cholinergic basal forebrain and is especially useful in treating neurodegenerative conditions such as |
| 09/17/2002 | US6451305 Methods for stimulating T cell responses to tumor cells expressing LFA-3 and a CD28 or CTLA4 ligand |
| 09/17/2002 | US6451303 Method for treating a human patient for coronary artery disease, comprising administering into one or more coronary vessels in a human patient in need of treatment for coronary artery disease an effective amount of a recombinant fibroblast |
| 09/17/2002 | US6450681 Dissolving in liquid; agitation |
| 09/17/2002 | CA2278878C Very large scale immobilized peptide synthesis |
| 09/17/2002 | CA2226342C Pap mutants that exhibit anti-viral and/or anti-fungal activity in plants |
| 09/17/2002 | CA2213001C Isolated nucleic acid molecule encoding peptides which form complexes with mhc molecule hla-cw*1601 and uses thereof |
| 09/17/2002 | CA2204151C Cdna encoding a bmp type ii receptor |
| 09/17/2002 | CA2187908C Non-splicing variants of gp350/220 |
| 09/17/2002 | CA2172989C Conotoxin peptides |
| 09/17/2002 | CA2113118C Novel growth factor-responsive progenitor cells which can be proliferated in vitro |
| 09/17/2002 | CA2111853C Substantially pure receptor like tgf-.beta.1 binding molecules and uses thereof |
| 09/17/2002 | CA2095534C Avirulent microbes and uses therefor |
| 09/17/2002 | CA2080272C Cyclic vasoactive peptides |
| 09/17/2002 | CA2047244C Genetically engineered immunoglobulins |
| 09/17/2002 | CA2045473C Compositions for treating ischemia-related neuronal damage |
| 09/16/2002 | CA2373468A1 Reg-like protein |
| 09/15/2002 | CA2373454A1 Recombinant infectious laryngotracheitis virus vaccine |
| 09/12/2002 | WO2002070744A2 Adenoviral library assay for e2f regulatory genes and methods and compositions for screening compounds |
| 09/12/2002 | WO2002070738A2 Diagnosis and treatment of blood disorders |
| 09/12/2002 | WO2002070727A2 Polynucleotide encoding a novel human potassium channel beta-subunit, k+betam6, expressed highly in the small intestine |
| 09/12/2002 | WO2002070725A1 Carrier chimeric proteins, targeted carrier chimeric proteins and preparation thereof |
| 09/12/2002 | WO2002070722A1 Use of fusion proteins whose n-terminal part is a hirudin derivative for the production of recombinant proteins via secretion by yeasts |
| 09/12/2002 | WO2002070716A1 Allergen ole e 9 from olea europaea, recombinant dna coding for said allergen, the production and use thereof |
| 09/12/2002 | WO2002070711A1 Vaccine |
| 09/12/2002 | WO2002070709A2 Molecules for disease detection and treatment |
| 09/12/2002 | WO2002070708A2 Glutamate receptor modulatory proteins and nucleic acids encoding them |
| 09/12/2002 | WO2002070707A2 Novel gpcr-like proteins and nucleic acids encoding same |
| 09/12/2002 | WO2002070706A2 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 09/12/2002 | WO2002070705A2 Human 7tm proteins and polynucleotides encoding them |
| 09/12/2002 | WO2002070704A2 Adipocyte complement related protein zacrp11 |
| 09/12/2002 | WO2002070703A2 Cell visual characteristic-modifying sequences |
| 09/12/2002 | WO2002070702A2 Polypeptides capable of interacting with smad polypeptide |
| 09/12/2002 | WO2002070701A2 Novel human gnrh receptor |
| 09/12/2002 | WO2002070700A1 Polynucleotide useful for modulating cancer cell proliferation |
| 09/12/2002 | WO2002070699A2 Cofactors of the estrogen receptor alpha and methods of use |
| 09/12/2002 | WO2002070698A2 Modified ciliary neurotrophic factor (cntf) with reduced immunogenicity |